Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2006
02/21/2006US7001724 Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases
02/21/2006US7001723 Catalytic RNAs with aminoacylation activity
02/21/2006US7001722 Parallel primer extension approach to nucleic acid sequence analysis
02/21/2006US7001721 Nucleic acid sequence identification
02/21/2006US7001720 Cloning of a gene mutation for parkinson's disease
02/21/2006US7001719 Devices and methods for microorganism detection
02/21/2006US7001718 Prevent complexing of Dna and ligand; viricides; drug mixture with carrier
02/21/2006US7001717 Charcoal stabilization of phenyl phosphates
02/21/2006US7001716 Continuous flow methods for monitoring time dependent reactions
02/21/2006US7001599 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects
02/21/2006US7001587 Administering labeled water to individual over time for label to be incorporated into proteins or peptides, obtaining body tissues or fluids from individual, detecting incorporation of label in proteins or peptides to determine biosynthetic rate
02/21/2006CA2309340C Pyrimidine derivatives for labeled binding partners
02/21/2006CA2309280C Improved electrochemical biosensor test strip
02/21/2006CA2274174C Glucose sensor
02/21/2006CA2110401C Method for the selection of genetically transformed cells and compounds for use in the method
02/21/2006CA2091181C Cloning of chicken anaemia dna
02/21/2006CA2032381C Viral agent
02/19/2006CA2512599A1 A method to reduce false positive results
02/17/2006CA2478138A1 Cxcl10-based diagnosis and treatment of respiratory illnesses
02/16/2006WO2006017841A2 Genetic loci associated with fusarium solani tolerance in soybean
02/16/2006WO2006017840A2 Genetic loci associated with iron deficiency tolerance in soybean
02/16/2006WO2006017833A2 Genetic loci associated with phytophthora tolerance in soybean
02/16/2006WO2006017832A2 Modular compositing-multiple lot screening protocols for detection of pathogens, microbial contaminants and/or constituents
02/16/2006WO2006017751A2 Methods for the detection of molecular interactions within cells
02/16/2006WO2006017635A2 Isolation, gene expression, and chemotherapeutic resistance of motile cancer cells
02/16/2006WO2006017621A2 IRAK1c SPLICE VARIANT AND ITS USE
02/16/2006WO2006017573A2 Method for the early detection of pancreatic cancer and other gastrointestinal disease conditions
02/16/2006WO2006017549A2 Cell-based kinase assay
02/16/2006WO2006017531A2 Assays and methods using biomarkers
02/16/2006WO2006017432A2 A polynucleotide nanomechanical device that acts as an artificial ribosome and translates dna signals into polymer assembly instructions
02/16/2006WO2006017342A2 Assay methods for enzymes associated with sulfation
02/16/2006WO2006017325A2 Aav vector compositions and methods for enhanced expression of immunoglobulins the same
02/16/2006WO2006017274A2 Systems and methods for sample modification using fluidic chambers
02/16/2006WO2006017249A2 Evanescent microwave probe with enhanced resolution and sensitivity
02/16/2006WO2006017206A2 Flavivirus vaccine
02/16/2006WO2006017196A1 Stable cyanine dye phosphoramidites
02/16/2006WO2006017156A2 Methods for identifying a candidate for treatment of obesity
02/16/2006WO2006017151A2 Identification of makers in esophageal cancer, colon cancer, head and neck cancer and melanoma
02/16/2006WO2006017150A2 Identification of markers in lung and breast cancer
02/16/2006WO2006017083A2 Methods and compositions for phenotype identification based on nucleic acid methylation
02/16/2006WO2006016692A1 Knockout nonhuman animal
02/16/2006WO2006016392A2 Complex able to detect an analyte, method for its preparation and uses thereof
02/16/2006WO2006016274A2 Quantitative detection of hdv by real-time rt-pcr
02/16/2006WO2006016110A1 Methods and kit for the prognosis of breast cancer
02/16/2006WO2006015991A1 Identification of the genotype of the human papillomavirus with restriction enzyme cviri
02/16/2006WO2006015976A1 Diagnostic and therapeutic use of a plasma membrane atpase
02/16/2006WO2006015961A2 Enzyme-based time temperature indicator
02/16/2006WO2006001810A3 Improved inhibitor nucleic acids
02/16/2006WO2006001695A3 A method for selecting a gene involved in nisin resistance in bacteria
02/16/2006WO2005121366A8 Gene marker and utilization of the same
02/16/2006WO2005119263A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 92 (gpr92)
02/16/2006WO2005116622B1 Connector configuration for electrochemical cells and meters for use in combination therewith
02/16/2006WO2005116197A3 Adamts-8 proteins and uses thereof
02/16/2006WO2005116195A3 Method for identifying pde5-modulators
02/16/2006WO2005114218A3 Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule
02/16/2006WO2005113830A3 System and method for grouping precursor and fragment ions using selected ion chromatograms
02/16/2006WO2005113814A3 Biomarkers of chronic pelvic pain syndrome
02/16/2006WO2005111226A3 Characterization of mcra subunits and uses thereof
02/16/2006WO2005106036A3 Methods and compositions for assaying analytes
02/16/2006WO2005103299A3 Rnai-based target identification and validation
02/16/2006WO2005103284A3 Trend analysis and statistical process control using multitargeted screening assays
02/16/2006WO2005102379A3 Nucleic acid based assays for identification of fc receptor polymorphisms
02/16/2006WO2005077983A3 Modulating p38 kinase activity
02/16/2006WO2005073405A3 Catalytic polynucleotide and its use for determination of analytes
02/16/2006WO2005062770A3 Method for conducting pharmacogenomics-based studies
02/16/2006WO2005054517A3 Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
02/16/2006WO2005052180A3 Ntrk1 genetic markers associated with progression of alzheimer’s disease
02/16/2006WO2005050224A3 Small molecule and peptide arrays and uses thereof
02/16/2006WO2005047509A8 The mycolactone locus : an assembly line for producing novel polyketides, with therapeutic and prophylatic uses
02/16/2006WO2005039573A3 Biomarkers for the prediction of drug-induced diarrhoea
02/16/2006WO2005007830A3 Methods and compositions for diagnosis, staging and prognosis of prostate cancer
02/16/2006WO2004097003A3 Multiply-primed amplification of nucleic acid sequences
02/16/2006WO2004096992A3 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
02/16/2006WO2004083448A3 Molecular differences between species of the m.tuberculosis complex
02/16/2006WO2004063701A3 Methods of diagnosing and treating cancer
02/16/2006WO2004063326A3 Proteorhodopsin mutants with improved optical characteristics
02/16/2006WO2004048451A3 Optical information carrier comprising immobilized proteorhodopsin
02/16/2006WO2004037986A3 Map2k6 as modifier of branching morphogenensis and methods of use
02/16/2006WO2004035805A3 Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemoresistance
02/16/2006WO2003091402A3 N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS
02/16/2006WO2003083058A3 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
02/16/2006WO2003066883A3 A transcription amplification system for molecular imaging
02/16/2006WO2003050293A3 hGC-1, A GENE ENCODING A MEMBER OF THE OLFACTOMEDIN-RELATED PROTEIN FAMILY
02/16/2006WO2003025129A3 Neurotransmission-associated proteins
02/16/2006WO2002081639A3 Gene brcc2 and diagnostic and therapeutic uses thereof
02/16/2006US20060037095 Corn event TC1507 and methods for detection thereof
02/16/2006US20060037090 include muscle mass and/or fat deposition lean meat, lean back fat, sow prolificacy and/or sow longevity; insulin-like growth factor 2 (IGF2); drug screening
02/16/2006US20060037088 Gene expression levels as predictors of chemoradiation response of cancer
02/16/2006US20060036089 33 human secreted proteins
02/16/2006US20060036086 Use of signal transduction inhibitors and combination therapies for the prevention or treatment of cancer and angiogenesis related diseases
02/16/2006US20060036085 Solution containing DNA in mixture with other components is passed over support on which is covalently coupled an pyrimidine-rich oligonucleotide capable of hybridizing with a specific sequence present on the DNA
02/16/2006US20060036078 Fluorescent proteins
02/16/2006US20060036077 Gamma secretase substrates and in vitro assays
02/16/2006US20060035929 Compositions and methods containing substituted quinolines and substituted diphenylsulfones
02/16/2006US20060035856 Purified polypeptides having IL-13 receptor activity
02/16/2006US20060035855 Purified polypeptides having IL-13 receptor activity
02/16/2006US20060035813 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors
02/16/2006US20060035786 use of a polypeptide with the biological activity of sucrose-6-phosphate phosphatase which, if not present, brings about growth retardation symptoms and chlorotic leaves; method for identifying herbicidal or growth-regulatory compounds which inhibit the enzyme; herbicides or growth regulators
02/16/2006US20060035387 Non-specific binding resistant protein arrays and methods for making the same
02/16/2006US20060035379 Genes encoding wheat starch synthases and uses thereof